Cancer Research Division, Cancer Council NSW, NSW, Australia.
Cancer Research Division, Cancer Council NSW, NSW, Australia; General Surgical Department, Wollongong Hospital, NSW, Australia.
Eur Urol. 2018 Jun;73(6):859-867. doi: 10.1016/j.eururo.2017.08.013. Epub 2017 Aug 26.
Long-term psychological well-being and quality-of-life are important considerations when deciding whether to undergo active treatment for low-risk localised prostate cancer.
To assess the long-term effects of active surveillance (AS) and/or watchful waiting (WW) on psychological and quality-of-life outcomes for low-risk localised prostate cancer patients.
DESIGN, SETTING, AND PARTICIPANTS: The Prostate Cancer Care and Outcome Study is a population-based prospective cohort study in New South Wales, Australia. Participants for these analyses were low-risk localised prostate cancer patients aged <70 yr at diagnosis and participated in the 10-yr follow-up.
Validated instruments assessed outcomes relating to six health-related quality-of-life and nine psychological domains relevant to prostate cancer patients. Adjusted mean differences (AMDs) in outcome scores between prostate cancer treatment groups were estimated using linear regression.
At 9-11 yr after diagnosis, patients who started AS/WW initially had (1) higher levels of distress and hyperarousal than initial radiation/high-dose-rate brachytherapy patients (AMD=5.9; 95% confidence interval or CI [0.5, 11.3] and AMD=5.4; 95% CI [0.2, 10.5], respectively), (2) higher levels of distress and avoidance than initial low-dose-rate brachytherapy patients (AMD=5.3; 95% CI [0.2, 10.3] and AMD=7.0; 95% CI [0.5, 13.5], respectively), (3) better urinary incontinence scores than initial radical prostatectomy patients (AMD=-9.1; 95% CI [-16.3, -2.0]), and (4) less bowel bother than initial radiation/high-dose-rate brachytherapy patients (AMD=-16.8; 95% CI [-27.6, -6.0]). No other significant differences were found. Limitations include participant attrition, inability to assess urinary voiding and storage symptoms, and nonrandom treatment allocation.
Notwithstanding some long-term differences between AS/WW and various active treatment groups in terms of distress, hyperarousal, avoidance, urinary incontinence, and bowel bother, most long-term outcomes were similar between these groups.
This study assessed the long-term psychological and quality-of-life impacts of initially monitoring rather than actively treating low-risk prostate cancer. The results suggest that initial monitoring rather than active treatment has only a minor impact on subsequent long-term psychological and quality-of-life outcomes.
在决定是否接受低危局限性前列腺癌的积极治疗时,长期的心理幸福感和生活质量是重要的考虑因素。
评估主动监测(AS)和/或观察等待(WW)对低危局限性前列腺癌患者心理和生活质量结果的长期影响。
设计、地点和参与者:前列腺癌护理和结局研究是澳大利亚新南威尔士州的一项基于人群的前瞻性队列研究。这些分析的参与者是在诊断时年龄<70 岁且参加了 10 年随访的低危局限性前列腺癌患者。
使用验证过的工具评估了与前列腺癌患者相关的六个健康相关生活质量和九个心理领域的结局。使用线性回归估计前列腺癌治疗组之间结局评分的调整平均差异(AMD)。
在诊断后 9-11 年,最初开始 AS/WW 的患者与(1)初始放射治疗/高剂量率近距离放射治疗患者相比,有更高的困扰和高度警觉水平(AMD=5.9;95%置信区间或 CI [0.5,11.3]和 AMD=5.4;95% CI [0.2,10.5]),(2)与初始低剂量率近距离放射治疗患者相比,有更高的困扰和回避水平(AMD=5.3;95% CI [0.2,10.3]和 AMD=7.0;95% CI [0.5,13.5]),(3)与初始根治性前列腺切除术患者相比,有更好的尿失禁评分(AMD=-9.1;95% CI [-16.3,-2.0]),以及(4)与初始放射治疗/高剂量率近距离放射治疗患者相比,有更少的肠困扰(AMD=-16.8;95% CI [-27.6,-6.0])。未发现其他显著差异。局限性包括参与者流失、无法评估尿流和储存症状以及非随机治疗分配。
尽管在困扰、高度警觉、回避、尿失禁和肠困扰方面,AS/WW 与各种主动治疗组之间存在一些长期差异,但这些组之间的大多数长期结局相似。
本研究评估了最初监测而不是积极治疗低危前列腺癌对长期心理和生活质量的影响。结果表明,最初的监测而不是积极治疗对随后的长期心理和生活质量结果只有轻微影响。